Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoACT: Sipuleucel-T in Localized Prostate Cancer
NCT00715104Phase 2Completed
- Sponsor
- Dendreon
- Start
- Jul 2008
- Primary completion
- Dec 2012
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of sipuleucel-T in prostate cancer (PCa), sponsored by Dendreon. Started Jul 2008; status: completed.
02
Drugs
sipuleucel-T
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00715104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00715104.